Hogan v. Novo Nordisk, Inc.
| Kerry Hogan |
| Novo Nordisk, Inc. |
| 1:2022cv01384 |
| December 23, 2022 |
| US District Court for the Northern District of New York |
| Therese Wiley Dancks |
| Gary L Sharpe |
| Civil Rights: Jobs |
| 28 U.S.C. ยง 1441 Notice of Removal |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 6, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 14 DEMAND for Trial by Jury by Kerry Hogan. (Davenport, Paul) |
Filing 13
TEXT ORDER: Plaintiff is directed to file a jury demand by 2/10/2023. Plaintiff to file joint status report by 5/15/2023 re: status of discovery, whether R. 33 and 34 Requests have been timely served and responded to, any discovery issues, and depositions scheduled, if any. SO ORDERED by Magistrate Judge Therese Wiley Dancks on 2/2/2023. (sg)
|
|
Filing 12
ORDER REFERRING CASE to Mandatory Mediation: Deadline for Mediator Selection is 3/2/2023. Deadline for completion of Mandatory Mediation is 6/2/2023. Signed by Magistrate Judge Therese Wiley Dancks on 2/2/2023. (sg)
|
|
Filing 11
UNIFORM PRETRIAL SCHEDULING ORDER: Anticipated length of trial: 5 days, to be held at Albany NY. Rule 33 and 34 Requests to be served by 2/28/2023. Joinder of Parties due by 4/14/2023. Amended Pleadings due by 4/14/2023. Plaintiffs Expert Disclosure Deadline is 8/3/2023. Defendants Expert Disclosure Deadline is 9/18/2023. Rebuttal Expert Disclosure Deadline is 10/2/2023. Discovery due by 11/1/2023. Discovery Motions due 11/15/2023. Dispositive Motions to be filed by 12/15/2023. Mandatory Mediation deadline is 6/2/2023. Signed by Magistrate Judge Therese Wiley Dancks on 2/2/2023. (sg)
|
| TEXT Minute Entry for proceedings held before Magistrate Judge Therese Wiley Dancks: Telephone Initial Pretrial Conference held on 2/2/2023. Appearances: Paul Davenport, Esq. for Plaintiff; Michael Fleming, Esq. for Defendant. Court reviews Civil Case Management Plan. Rule 26 Disclosures completed. Plaintiff to provide authorizations for any providers of treatment associated with the claims by 2/17/2023. Stipulated protective order to be submitted for Court approval by 3/21/2023. Case referred into Mandatory Mediation. Pretrial deadlines are established, a scheduling order and mediation referral order will be issued. (sg) |
| Filing 10 CIVIL CASE MANAGEMENT PLAN by Novo Nordisk, Inc.. (Fleming, Michael) |
| ***PLEASE READ*** IMPORTANT TEXT NOTICE FROM THE COURT re: the 2/2/2023 11:30am Telephone Rule 16 Conference: Counsel are directed to call the following number for this conference: 1-315-691-0477, and enter ID code 760750440 to connect to the conference. (sg) |
|
Filing 9
TEXT ORDER granting #8 Motion for Limited Admission Pro Hac Vice of Terry Johnson, Esq. Counsel is hereby advised that as of January 16, 2018, the NYND has converted to NextGen. Due to this conversion, you must now register for Pro Hac Vice access through your PACER account. This is the only notice you will receive concerning this requirement. You will not have access to electronically file in this case until your Pro Hac Vice request has been processed through the PACER system. Step-by-step instructions on how to complete this process are available at http://www.nynd.uscourts.gov/attorney-admissions-nextgen. SO ORDERED by Magistrate Judge Therese Wiley Dancks on 1/17/2023. (sg)
|
| Filing 8 MOTION for Limited Admission Pro Hac Vice of Terry D. Johnson Filing fee $100, receipt number ANYNDC-6156750. (Attachments: #1 Declaration of Sponsor, #2 Petition for Admission, #3 New Attorney E-Filing Registration Form, #4 Certificate of Good Standing) Motions referred to Therese Wiley Dancks. (Fleming, Michael) |
| CLERK'S CORRECTION OF DOCKET ENTRY re #6 FRCP 7.1 Corporate Disclosure Statement: Clerk added "identifying Other Affiliates Novo Nordisk U.S. Holdings, Inc. and Novo Nordisk A/S" to this docket entry, since these were missing in the docket entry when the original document was filed. (hmr) |
| Filing 7 ANSWER to Complaint by Novo Nordisk, Inc..(Fleming, Michael) |
| Filing 6 FRCP 7.1 CORPORATE DISCLOSURE STATEMENT by Novo Nordisk, Inc. identifying Corporate Parent Novo Nordisk US Commercial Holdings, Inc.; identifying Other Affiliates Novo Nordisk U.S. Holdings, Inc. and Novo Nordisk A/S for Novo Nordisk, Inc... (Fleming, Michael) Modified on 1/3/2023 (hmr, ). |
| Filing 5 NOTICE by Novo Nordisk, Inc. Civil Cover Sheet (Fleming, Michael) |
| TEXT NOTICE OF FILING DEFICIENCY as to Novo Nordisk, Inc. NOTICE IS HEREBY GIVEN of the following Filing Deficiency: Other Deficiency - A Civil Cover Sheet was not initially filed with this case. The correction(s) should be made within 3 days of this notice. Notice of Filing Deficiency Deadline 1/3/2023 (egr) |
| ***Answer due date updated for Novo Nordisk, Inc. answer due 1/3/2023. (egr) |
| Filing 4 NOTICE OF ADMISSION REQUIREMENT as to Party Novo Nordisk, Inc.; Attorney Terry D. Johnson, Esq., Email address is terry.johnson@morganlewis.com. Phone number is 609-919-6689. Sent via mail and email. Admissions due by 1/10/2023. (egr) |
| Filing 3 G.O. 25 FILING ORDER ISSUED: Initial Conference set for 2/2/2023 at 11:30 AM by Telephone Conference before Magistrate Judge Therese Wiley Dancks. Civil Case Management Plan must be filed and Mandatory Disclosures are to be exchanged by the parties on or before 1/26/2023. (Pursuant to Local Rule 26.2, mandatory disclosures are to be exchanged among the parties but are NOT to be filed with the Court.) (egr) |
| Filing 2 STATE COURT COMPLAINT relating to #1 Notice of Removal, filed by Plaintiff(s) in Supreme Court, State of New York: Schenectady County. (egr) Modified on 12/27/2022 to change date to correct date of filing. (egr). |
| Filing 1 NOTICE OF REMOVAL from State of New York, Supreme Court of Schenectady County, case number 2022-658 (Filing fee $402 receipt number ANYNDC-6141645) filed by Novo Nordisk, Inc.. (Attachments: #1 Exhibit A - State Court Summons, #2 Exhibit B - State Court Complaint, #3 Exhibit C - Affidavit of Service, #4 Exhibit D - Record from NY Secratary of State, #5 Exhibit E - Affidavit of Follow up Service, #6 Exhibit F - Letter from Plaintiffs Counsel, #7 Exhibit G - 2021 W2, #8 Exhibit H - Declaration of Alexandre C. Halow)(egr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
| Search for this case: Hogan v. Novo Nordisk, Inc. | |
|---|---|
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
| Plaintiff: Kerry Hogan | |
| Represented By: | Paul E. Davenport |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Defendant: Novo Nordisk, Inc. | |
| Represented By: | Michael Fleming |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
